Tuesday, December 09, 2008 9:31:47 AM
LAKE FOREST, CA--(MARKET WIRE)--Dec 9, 2008 -- CryoPort, Inc. (OTC BB:CYRX.OB - News) today announced it has named Larry Stambaugh to the Board of Directors. Mr. Stambaugh has also been elected to the position of Chairman of the Board.
Related Quotes
Symbol Price Change
CYRX.OB 0.50 0.0
Mr. Stambaugh is currently a Principal of Apercu Consulting and sits on the boards of several companies. At Apercu, Mr. Stambaugh serves as an advisor to several private and public boards and CEOs, concentrating on strategic business direction, turnarounds and board governance. Mr. Stambaugh brings to CryoPort more than 30 years of successful experience building global businesses and setting strategies. He also brings an extensive background in life sciences and clean tech including relationships with and knowledge of Contract Research Organizations, and biotech and pharmaceutical companies.
Peter Berry, CEO of CryoPort, stated, "Recruiting a successful and experienced biotech/clean tech executive like Larry Stambaugh to join our Board of Directors at this time will enhance CryoPort's ability to move from an early revenue stage company to full global commercialization. We are extremely pleased to announce that Mr. Stambaugh has agreed to join the Board of Directors."
"I believe that CryoPort has an exciting opportunity to launch a game changing and environmentally friendly product in the global frozen shipment business," stated Mr. Stambaugh. "I look forward to working with the board and management on the challenges of growing the company and creating shareholder value."
Related Quotes
Symbol Price Change
CYRX.OB 0.50 0.0
Mr. Stambaugh is currently a Principal of Apercu Consulting and sits on the boards of several companies. At Apercu, Mr. Stambaugh serves as an advisor to several private and public boards and CEOs, concentrating on strategic business direction, turnarounds and board governance. Mr. Stambaugh brings to CryoPort more than 30 years of successful experience building global businesses and setting strategies. He also brings an extensive background in life sciences and clean tech including relationships with and knowledge of Contract Research Organizations, and biotech and pharmaceutical companies.
Peter Berry, CEO of CryoPort, stated, "Recruiting a successful and experienced biotech/clean tech executive like Larry Stambaugh to join our Board of Directors at this time will enhance CryoPort's ability to move from an early revenue stage company to full global commercialization. We are extremely pleased to announce that Mr. Stambaugh has agreed to join the Board of Directors."
"I believe that CryoPort has an exciting opportunity to launch a game changing and environmentally friendly product in the global frozen shipment business," stated Mr. Stambaugh. "I look forward to working with the board and management on the challenges of growing the company and creating shareholder value."
Recent CYRX News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/05/2026 06:36:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/04/2026 08:30:40 PM
- Cryoport Reports First Quarter 2026 Financial Results • PR Newswire (US) • 05/04/2026 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/24/2026 12:00:17 AM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/22/2026 08:32:31 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/22/2026 08:31:32 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/22/2026 08:30:45 PM
- Cryoport to Report First Quarter 2026 Financial Results on May 4, 2026 • PR Newswire (US) • 04/20/2026 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 10:32:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 12:01:25 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 12:00:50 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 12:00:13 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:01:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:00:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:00:11 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/12/2026 08:17:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/03/2026 10:10:46 PM
- Cryoport Reports Fourth Quarter and Full-Year 2025 Financial Results • PR Newswire (US) • 03/03/2026 09:05:00 PM
- Cryoport to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026 • PR Newswire (US) • 02/17/2026 01:00:00 PM
- Cryoport's MVE Biological Solutions Introduces New Fusion® 800 Series • PR Newswire (US) • 02/11/2026 01:30:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/05/2026 09:56:32 PM


